UK Markets close in 7 hrs 2 mins
  • FTSE 100

    7,560.09
    +3.86 (+0.05%)
     
  • FTSE 250

    19,409.28
    +46.00 (+0.24%)
     
  • AIM

    852.36
    -0.96 (-0.11%)
     
  • GBP/EUR

    1.1633
    -0.0027 (-0.23%)
     
  • GBP/USD

    1.2286
    -0.0010 (-0.0799%)
     
  • BTC-GBP

    14,094.44
    +170.82 (+1.23%)
     
  • CMC Crypto 200

    410.72
    +9.30 (+2.32%)
     
  • S&P 500

    4,071.70
    -4.87 (-0.12%)
     
  • DOW

    34,429.88
    +34.88 (+0.10%)
     
  • CRUDE OIL

    81.06
    +1.08 (+1.35%)
     
  • GOLD FUTURES

    1,811.80
    +2.20 (+0.12%)
     
  • NIKKEI 225

    27,820.40
    +42.50 (+0.15%)
     
  • HANG SENG

    19,518.29
    +842.94 (+4.51%)
     
  • DAX

    14,467.96
    -61.43 (-0.42%)
     
  • CAC 40

    6,720.48
    -21.77 (-0.32%)
     

Analysts optimistic on CVS outlook

The CVS (LON:CVSG) share price has risen by 8.86% over the past month and it’s currently trading at 1,770p. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue.

According to the company’s analysts, there are certainly reasons to think it will continue to perform well in the year ahead. In terms of trading recommendations, CVS currently has:

  • 4 Buy recommendations

  • 0 Hold recommendations

  • 0 Sell recommendations

This suggests that analysts are generally positive about the outlook.

GET MORE DATA-DRIVEN INSIGHTS INTO LON:CVSG »

Researching beyond broker forecasts

At its current price of 1,770p, shares in CVS are trading at a discount of -37.6% to its 52 week high price. The 1-year performance of the shares has been -19.0%.

While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of CVS it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with CVS that you can find out about here.